Join CO-ADD on Thursday 2 November for a workshop on the ins and outs of drug discovery and development, part of the National AMR Forum to be held in Brisbane, Australia
CO-ADD Drug Discovery and Development Workshop
Thursday 2 November, 12:00pm for a 12:30pm start - 4:30pm
Pharmacy Australia Centre of Excellence (PACE), Level 4, 20 Cornwall St, Woolloongabba, QLD, 4102, Australia
Register for a place at the workshop (limited to 35 attendees)
If you are unable to attend the workshop in person, you can join the workshop via video conference using Zoom. You will need to sign up for Zoom. You will receive an email from CO-ADD with a link to join the workshop.
Calling all clinicians, researchers and chemists interested in discovery and development of new antibiotics! This CO-ADD hosted workshop will give attendees an insight into the identification of new antimicrobials and pathways to development as potential antimicrobial drugs. The workshop will consist of 30 - 40 minute presentations followed by a panel discussion. Afternoon tea will be provided.
- The antibiotic pipeline
- Chemoinfomatic and screening approaches to finding new antibiotics
- Academic and commercial case studies
- The relevance of PK/PD for antibiotic development
- Dr Mark Blaskovich, Dr Johannes Zuegg and Dr Karl Hansford, CO-ADD, The University of Queensland
- Dr Fekade Sime, School of Pharmacy, The University of Queensland
- Wim Meutermans, VAST Bioscience Pty Ltd
The National AMR Forum is in Brisbane on Friday 3 November, 2017. The AMR Forum will be preceeded by free workshops on Thursday 2 November. Please register your interest for the workshops here.
The Forum will be held at the Pharmacy Australia Centre of Excellence (PACE) L4, 20 Cornwall St Woolloongabba, QLD.
Alison Holmes - Professor of Infectious Diseases at Imperial College and the Director of Infection Prevention and Control (DIPC) and Associate Medical Director for Imperial College Healthcare NHS Trust
Anton Peleg - Professor of Infectious Diseases and Microbiology; Director, Department of Infectious Diseases The Alfred Hospital and Monash University, Melbourne
The scientific meeting is a collaboration between Queensland Statewide Antimicrobial Stewardship Program, CRE REDUCE, the UQ's Institute for Molecular Bioscience, the National Centre for Antimicrobial Stewardship (NCAS) based at the Peter Doherty Institute for Infection and Immunity and Queensland University of Technology.